Neurokinin NK1 receptor antagonists may have therapeutic potential in the treatment of anxiety and depression. Species variants in the NK1 receptor result in reduced affinity of NK1 receptor ...
Several neurokinin NK1 receptor antagonists currently being developed for anxiety and depression have reduced affinity for the rat and mouse NK1 receptor compared with human. Consequently, it has ...
An "elevated plus maze" test was carried out one hour after mice drank water or Matcha green tea. (A) Mouse movement trajectory, (B) & (C) Percentage of time spent and distance traveled (cm) of mice ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results